Zacks Investment Research on MSN

OM stock gains on FDA clearance for next-gen Tablo dialysis system

Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, ...

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 ...
MassDevice

Outset Medical wins FDA nod for next-gen Tablo hemodialysis system

Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.
Medical Device Network on MSN

Outset Medical secures FDA clearance for Tablo haemodialysis system

Outset Medical plans to begin shipping the updated platform during the second quarter of 2026.
Investing.com South Africa

Outset Medical stock jumps after FDA clears next-gen Tablo platform

Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...